Comments
Sanofi Pasteur, the vaccine division of Sanofi, announced here on Tuesday that the world’s first dengue vaccine could be available in the second half of 2015.
Results of the last stage of the clinical study showed that the dengue vaccine gives a 95.5 per cent protection against severe dengue and an 80.3 per cent reduction in the risk of hospitalisation.
Dengue has been a serious challenge to public health as it affects lakhs of people annually in India, the company said.
Sanofi Pasteur will file for registration of its vaccine candidate and subject to regulatory approval, the world’s first dengue vaccine could be available in the second half of 2015, it said.
The vaccine will help prevent patients who are at risk of acquiring the v the release said, adding that company’s phase III efficacy clinical study programme for its dengue vaccine candidate was conducted in over 31,000 participants across 10 endemic countries in Asia and Latin America.
“We plan to submit the vaccine for licensure in 2015 in endemic countries where dengue is a public health priority,” President and CEO, Sanofi Pasteur, Olivier Charmeil said.
Country Head, Sanofi Pasteur, Dr Stephan Barth, said dengue is a serious health concern in India, causing a significant but under-reported burden.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.